![Sireesh Appajosyula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sireesh Appajosyula
Direktor/Vorstandsmitglied bei
HEPION PHARMACEUTICALS, INC.
Vermögen: 273 364 $ am 31.07.2026
Profil
Sireesh Appajosyula currently works at Hepion Pharmaceuticals, Inc., as Director from 2026, Highpoint Pharmaceuticals LLC, as Managing Member from 2018, and Channel Bioconsulting LLC, as Managing Partner from 2015.
Dr. Appajosyula also formerly worked at Canton Strategic Holdings, Inc., as Chief Financial Officer in 2025, 9 Meters Biopharma, Inc., as SVP-Corporate Development & Operations, and Salix Pharmaceuticals, Inc., as Head-Business Development.
Dr. Appajosyula received his undergraduate degree from Rutgers State University of New Jersey and doctorate degree from Ernest Mario School of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.08.2026 | 3’250’000 ( 3.6% ) | 149 500 $ | 31.07.2026 | |
| 16.06.2026 | 64’178 ( 0.08% ) | 123 864 $ | 31.07.2026 |
Aktive Positionen von Sireesh Appajosyula
| Unternehmen | Position | Beginn |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 16.03.2026 |
Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 01.01.2018 |
Channel Bioconsulting LLC | Corporate Officer/Principal | 01.01.2015 |
Ehemalige bekannte Positionen von Sireesh Appajosyula
| Unternehmen | Position | Ende |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Vorstandsvorsitzender | - |
| 9 METERS BIOPHARMA, INC. | Geschäftsführer | 17.07.2023 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Sireesh Appajosyula
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
Highpoint Pharmaceuticals LLC | |
Channel Bioconsulting LLC |
